Physician profile
Benjamin C Griggs
NPI 1073601167
$1,415.77
in general payments reported to CMS, 2019-2025
27 companies · $232 in 2025
The $232 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $81.40 · 2021: $341 · 2022: $317 · 2023: $117 · 2024: $141 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $490.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $490.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $402.55 | 2019-2022 | |
| Hologic Sales and Service, LLC | $171.33 | 2019-2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Aptima |
| Baxter Healthcare | $69.53 | 2025 | Perclot |
| Pfizer INC. | $69.12 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $58.92 | 2019-2023 | |
| Scynexis, INC. | $57.91 | 2022 | |
| Mayne Pharma Commercial LLC | $53.02 | 2021-2024 | |
| Evofem Biosciences, INC. | $50.33 | 2021-2022 | |
| Organon LLC | $44.01 | 2022-2024 | |
| Amgen INC. | $42.02 | 2019 | |
| Medtronic, INC. | $36.21 | 2021-2022 | |
| Millicent US INC | $35.11 | 2019-2020 | |
| Channel Medsystems, INC. | $34.20 | 2023 | |
| Exeltis, USA INC. | $32.79 | 2021 | |
| Sumitomo Pharma America, INC. | $31.35 | 2024-2025 | Myfembree |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $28.88 | 2020-2021 | |
| Dexcom, INC. | $28.85 | 2025 | Dexcom G6 Transmitter |
| Therapeuticsmd, INC. | $28.64 | 2019-2021 | |
| Astellas Pharma US INC | $28.02 | 2019-2024 | Veozah |
| Shield Therapeutics INC | $17.58 | 2025 | |
| Mission Pharmacal Company | $16.16 | 2019 | |
| Radius Health, INC. | $15.60 | 2025 | Tymlos |
| Minerva Surgical, INC | $15.52 | 2024 | |
| Myovant Sciences INC. | $12.72 | 2021 | |
| Meditrina | $12.50 | 2024 | |
| Mylan Pharmaceuticals INC. | $11.93 | 2021 | |
| Vivus LLC | $10.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Griggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.